LRRK2 and Parkinson disease: However, even when L2-PD patients share the same causal mutation, their clinical presentation, including age-at-disease-onset (AAO), is variable and some LRRK2 G2019S mutation carriers never manifest disease symptoms despite advanced age8–10.